SMTL ID : 7wcd.1

Cryo EM structure of SARS-CoV-2 spike in complex with TAU-2212 mAbs in conformation 4

Coordinates

PDB Format Compare

Method

ELECTRON MICROSCOPY

Oligo State

hetero-3-3-3-mer

Ligands

33 x NAG: 2-acetamido-2-deoxy-beta-D-glucopyranose(Post Translational Modification)

NAG.1: 3 residues within 4Å: Chain A: A.706, E.1072, N.1074 Ligand excluded by PLIP NAG.2: 2 residues within 4Å: Chain A: T.108, N.234 Ligand excluded by PLIP NAG.3: 2 residues within 4Å: Chain A: N.282 Chain G: K.558 Ligand excluded by PLIP NAG.4: 1 residues within 4Å: Chain A: N.1134 Ligand excluded by PLIP NAG.5: 4 residues within 4Å: Chain A: N.1098, T.1100, H.1101, F.1103 Ligand excluded by PLIP NAG.6: 2 residues within 4Å: Chain A: N.801, Q.804 Ligand excluded by PLIP NAG.7: 2 residues within 4Å: Chain A: N.709, G.1131 Ligand excluded by PLIP NAG.8: 1 residues within 4Å: Chain A: N.657 Ligand excluded by PLIP NAG.9: 2 residues within 4Å: Chain A: N.616, T.618 Ligand excluded by PLIP NAG.10: 1 residues within 4Å: Chain A: N.603 Ligand excluded by PLIP NAG.11: 3 residues within 4Å: Chain A: A.163, N.164, N.165 Ligand excluded by PLIP NAG.12: 3 residues within 4Å: Chain D: A.706, E.1072, N.1074 Ligand excluded by PLIP NAG.13: 2 residues within 4Å: Chain D: T.108, N.234 Ligand excluded by PLIP NAG.14: 2 residues within 4Å: Chain A: K.558 Chain D: N.282 Ligand excluded by PLIP NAG.15: 1 residues within 4Å: Chain D: N.1134 Ligand excluded by PLIP NAG.16: 4 residues within 4Å: Chain D: N.1098, T.1100, H.1101, F.1103 Ligand excluded by PLIP NAG.17: 2 residues within 4Å: Chain D: N.801, Q.804 Ligand excluded by PLIP NAG.18: 2 residues within 4Å: Chain D: N.709, G.1131 Ligand excluded by PLIP NAG.19: 1 residues within 4Å: Chain D: N.657 Ligand excluded by PLIP NAG.20: 2 residues within 4Å: Chain D: N.616, T.618 Ligand excluded by PLIP NAG.21: 1 residues within 4Å: Chain D: N.603 Ligand excluded by PLIP NAG.22: 3 residues within 4Å: Chain D: A.163, N.164, N.165 Ligand excluded by PLIP NAG.23: 3 residues within 4Å: Chain G: A.706, E.1072, N.1074 Ligand excluded by PLIP NAG.24: 2 residues within 4Å: Chain G: T.108, N.234 Ligand excluded by PLIP NAG.25: 2 residues within 4Å: Chain D: K.558 Chain G: N.282 Ligand excluded by PLIP NAG.26: 1 residues within 4Å: Chain G: N.1134 Ligand excluded by PLIP NAG.27: 4 residues within 4Å: Chain G: N.1098, T.1100, H.1101, F.1103 Ligand excluded by PLIP NAG.28: 2 residues within 4Å: Chain G: N.801, Q.804 Ligand excluded by PLIP NAG.29: 2 residues within 4Å: Chain G: N.709, G.1131 Ligand excluded by PLIP NAG.30: 1 residues within 4Å: Chain G: N.657 Ligand excluded by PLIP NAG.31: 2 residues within 4Å: Chain G: N.616, T.618 Ligand excluded by PLIP NAG.32: 1 residues within 4Å: Chain G: N.603 Ligand excluded by PLIP NAG.33: 3 residues within 4Å: Chain G: A.163, N.164, N.165 Ligand excluded by PLIP

Links

RCSB   PDBe   PDBe-KB   PDBj   PDBsum   CATH   PLIP

Citation

Li, R. et al., Conformational flexibility in neutralization of SARS-CoV-2 by naturally elicited anti-SARS-CoV-2 antibodies. Commun Biol (2022)

Release Date

2022-08-10

Peptides

Spike glycoprotein: ADG
Heavy chain: BEH
Light chain: CFI

SMTL:PDB

SMTL Chain Id:
PDB Chain Id:

A
H

D
J

G
C

B
E

E
G

H
A

C
F

F
I

I
B

Spike glycoprotein

Heavy chain

Light chain